Cathay Biotech Inc. (SHA:688065)
46.01
+0.58 (1.28%)
At close: Dec 5, 2025
Cathay Biotech Company Description
Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally.
The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands.
It also provides digital solutions for electrification, automation, and digitization for biological manufacturing.
The company’s products are used in textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, engineering materials, and other industries.
It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.
Cathay Biotech Inc.
| Country | China |
| Founded | 2000 |
| Industry | Chemicals |
| Sector | Materials |
| Employees | 1,735 |
| CEO | Xiucai Liu |
Contact Details
Address: Building 11 Shanghai, 201114 China | |
| Phone | 86 21 5080 1916 |
| Website | cathaybiotech.com |
Stock Details
| Ticker Symbol | 688065 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004447 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Dr. Xiucai Liu | Chairman and President |
| Chen Yang | Vice President, Core Technician and Chief Operating Officer |
| Huiqing Zang | Vice President, Secretary of the Board of Directors and Director |
| Yijun Du | Vice President |
| Jun Zuo | Vice President |
| Hong Guang Zhang | Vice President |
| Benliang Hou | Vice President |